Experts worry early detection tests like Galleri and CancerGuard are unproven and could drive up health care costs by ...
OPERA-02: a phase 3 randomized, double-blind, active-controlled study of palazestrant with ribociclib versus letrozole with ribociclib for the first-line treatment of ER+, HER2- advanced breast cancer ...
Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted ...
Researchers at the ESMO Congress said they want to confirm their findings in a prospective randomized controlled trial.
PHILADELPHIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) ...
Nanotechnology is the science of materials at the nanoscale, where matter behaves differently than it does at larger scales. The unique properties at this size have enabled the development of advanced ...
Refractory chronic cough is a condition with high unmet need and no FDA-approved therapies. RCC is defined as a persistent cough lasting >8 weeks despite treatment for an underlying condition (i.e., ...
LA JOLLA, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange ...
The team begins their first shrink wrap job while continuing scaffold assembly on a multi-level build. Material issues and tight workspace conditions add to the day's challenges. Trump Makes U-Turn On ...
FORT PIERCE, FL – Jury selection has begun in the criminal trial of a man accused of attempting to assassinate President Donald Trump at his Florida golf club during his reelection campaign nearly a ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from SinoMab Bioscience ...